MVA-BN respiratory syncytial virus vaccine could get first-to-market opportunity in China, says GlobalData
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
RSV is the most common viral cause of respiratory tract infections in newborns, young children, older adults, or the immunocompromised
Successfully removed peanut from the child’s left lung through bronchoscopy
Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment
Positive opinion could expand the role of Cosentyx (secukinumab) in reducing flare risk in pediatric enthesitis-related arthritis (ERA) and psoriatic arthritis (PsA) patients in the EU
The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease
The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone
Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19
Nirsevimab is the first investigational immunization designed to protect all infants across the RSV season with a single dose
There is a need for the Ministry of Health to put it on the priority list and address the issues, which are numerous
If granted, Nuvaxovid would be the first protein-based Covid-19 vaccine option for adolescents in Australia and New Zealand
Subscribe To Our Newsletter & Stay Updated